Terry Shaw's Strategic Insight Enhances RAAPID's Advisory Board

Terry Shaw's Influential Role in RAAPID

In a significant move for both the healthcare technology field and RAAPID, a company renowned for its AI-driven risk adjustment solutions, Terry Shaw has been appointed to the advisory board. Shaw, who previously held the position of President and CEO of AdventHealth, joins RAAPID with an extensive background in healthcare leadership centered around operational efficiency and financial performance.

A Stellar Career at AdventHealth

Terry Shaw served as the President and CEO of AdventHealth from 2016 until his recent career transition in 2025. Under his leadership, AdventHealth emerged as one of America’s leading faith-based health systems. The organization boasts an impressive network of over 50 hospital campuses, plus more than 2,000 care sites, and employs a workforce exceeding 100,000. This size and scale make Shaw’s experience especially valuable to RAAPID, as he has a unique insight into managing large healthcare operations effectively.

Over the years, Shaw has transitioned through various pivotal roles within AdventHealth, including Executive Vice President, Chief Financial Officer, and Chief Operating Officer. His journey has positioned him as a key figure within the healthcare sector, recognized as one of Modern Healthcare's “100 Most Influential People in Healthcare” for 2024.

Expert in Value-Based Care

RAAPID specializes in offering AI-powered solutions that streamline risk adjustment processes for healthcare payers and providers. The company's innovative platform utilizes advanced neuro-symbolic AI to identify chronic health issues, determine Hierarchical Condition Categories (HCC) codes, calculate risk scores, and analyze population health trends. Shaw's extensive experience in managing financial and clinical operations within a large health system aligns perfectly with the aims of RAAPID, as the company focuses on developing technologies that facilitate efficient, value-based care models.

In his new role, Shaw is anticipated to leverage his expertise to drive RAAPID’s initiatives forward. Chetan Parikh, the CEO and Founder of RAAPID, expressed high hopes for Shaw's contributions, stating, "Terry's exceptional track record of leading healthcare transformation and his deep understanding of both clinical excellence and financial performance make him an invaluable addition to our advisory board."

RAAPID’s Vision for the Future

RAAPID is committed to tackling one of healthcare's most pressing challenges: the need for accurate risk capture and documentation. Michael Clark, RAAPID's President and Chief Growth Officer, highlighted Shaw's arrival as a transformative step for the company, saying, "His strategic insights and operational expertise will help accelerate our mission to transform risk adjustment through purpose-built AI technology."

Shaw himself expressed enthusiasm about joining RAAPID, stating, "I'm excited to join RAAPID's advisory board and support their mission to revolutionize risk adjustment. Their AI-powered solutions are genuinely addressing significant value-based care challenges while enhancing patient care outcomes for both providers and payers."

The Future Looks Bright

As RAAPID forges ahead in the healthcare technology landscape, Shaw's invaluable experience in large operational settings will undoubtedly influence the direction of the company's advancements. The merging of Shaw's depth of knowledge with RAAPID's cutting-edge technology holds the potential to redefine risk adjustment practices and improve patient outcomes across the industry.

For further information about RAAPID’s innovative approaches and solutions in the healthcare field, visit www.raapidinc.com.